Early use of tocilizumab in hospitalized patients with severe and critical COVID-19 in the Province of Buenos Aires: a multicentric study
VB AN, T Varela, L Regairaz - Medicina, 2023 - europepmc.org
Methods Multicenter, retrospective cohort study including patients> 18 years hospitalized
between 7/1/2021-8/1/2022 with confirmed COVID-19, with 5, 6 and 7 points of WHO Ordinal …
between 7/1/2021-8/1/2022 with confirmed COVID-19, with 5, 6 and 7 points of WHO Ordinal …
Early use of tocilizumab in hospitalized patients with severe and critical COVID-19 in the Province of Buenos Aires: a multicentric study
M Salazar, ANV Baino, S González… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Introducción: El objetivo principal del estudio fue evaluar la mortalidad en los pacientes con
COVID-19 graves y críticos, que recibieron tocilizumab (TCZ)-un antagonista monoclonal …
COVID-19 graves y críticos, que recibieron tocilizumab (TCZ)-un antagonista monoclonal …